VenomAid Diagnostics is a MedTech company at the forefront of revolutionising snakebite care on a global scale by pioneering affordable diagnostics to reach previously neglected populations.
About The Project
We are currently working with Abingdon Health as our CDMO partner on development of a rapid snakebite diagnostic and, so far, we are greatly satisfied with the collaboration.
Results & Impact of Working With Abingdon Health
Abingdon’s ability to move quickly has been a major advantage, particularly regarding allowing for an accelerated timeline for a work package before an early-phase feasibility study in the clinic.
We find the team to be highly engaged, responsive, and adaptable; they were even rapidly able to deliver 200 additional prototypes with just a few days’ notice to support an on-site study.
The Abingdon team also engages deeply with the scientific challenges, including sample handling and sourcing clinical samples. They clearly and consistently communicate data-driven updates about the test development, enabling productive scientific, technical and regulatory discussions.
VenomAid Says
"Overall, Abingdon’s flexibility across timelines, budget, personnel, and resources allows us to progress at the pace we need, making them a highly effective development partner."
- Georgina Ross, PhD, Chief Technology Officer, VenomAid Diagnostics [Linkedin Profile]
